Dr Olivia Kates talks about appropriate use of antibiotics during the COVID-19 pandemic.

Prof Ana Santos Rutschman talks about the impact of intellectual property regimes on domestic and global responses to the COVID-19 pandemic.

Dr Steven Goodman talks about the ethical and scientific implications of breaking the blind of placebo-controlled COVID-19 vaccine trials.

Dr Arthur Caplan talks about ethical issues surrounding the development, production, and use of potential SARS-CoV-2 vaccine.

Dr Caleb Alexander examines the US Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's Disease.

Drs Stefano Bertozzi and Jeffrey Mackie-Mason talk about business models of scientific publishing that advance biomedical knowledge and discovery.

Taking care of patients whose cultures, belief systems, and family hierarchy structures differ from those on which many U.S. laws and regulations involves strategies—particularly regarding end-of-life care and surrogate decision making.

Taking care of patients whose cultures, belief systems, and family hierarchy structures differ from those on which many U.S. laws and regulations involves strategies—particularly regarding end-of-life care and surrogate decision making.